Insights

Strategic split Endo restructured via a 2025 merger with Mallinckrodt and formed two focused entities Keenova Therapeutics and Par Health, presenting cross-sell potential to branded and generics clients while enabling targeted outreach to each segment with distinct value propositions.

Private revitalization Post Chapter 11 emergence as Endo, Inc., the company is navigating a redefined ownership and strategy landscape, creating an opening for sales conversations around restructuring benefits, new financing options, and refreshed contract terms with health system and payer partners.

Therapeutics expansion Keenova Therapeutics focuses on branded therapies and Par Health on generics and sterile injectables, signaling opportunities to upsell clinical development services, manufacturing capabilities, and sterile injectable supply chain support to healthcare providers and wholesalers.

Digital and ops leverage Existing tech stack including AWS, SAP ERP, MasterControl and cyber risk controls suggests strong digital operations; leverage for selling GMP-compliant manufacturing, quality systems, serialization, and regulatory submissions to customers seeking scalable compliance-ready partnerships.

Financial momentum Revenue scale targets within the cited range and recent financing activities indicate ongoing investment activity; align value propositions around reliability, cost efficiency, and risk management to win business from payors, distributors, and hospital networks seeking stable partners.

Endo Tech Stack

Endo uses 8 technology products and services including Amazon Web Services, MasterControl, CREO, and more. Explore Endo's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • MasterControl
    Document Management Systems
  • CREO
    E-commerce
  • SAP ERP
    Enterprise Resource Planning
  • Modernizr
    Javascript Libraries
  • Oracle Essbase
    Middleware Software
  • NIST Cybersecurity Framework
    Security
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

Endo's Email Address Formats

Endo uses at least 1 format(s):
Endo Email FormatsExamplePercentage
Last.First@endo.comDoe.John@endo.com
72%
First.Last@endo.comJohn.Doe@endo.com
22%
First@endo.comJohn@endo.com
4%
LastFirst@endo.comDoeJohn@endo.com
2%

Frequently Asked Questions

What is Endo's phone number?

Minus sign iconPlus sign icon
You can contact Endo's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Endo's stock symbol?

Minus sign iconPlus sign icon
Endo is a publicly traded company; the company's stock symbol is ECYT.

What is Endo's official website and social media links?

Minus sign iconPlus sign icon
Endo's official website is endo.com and has social profiles on LinkedIn.

How much revenue does Endo generate?

Minus sign iconPlus sign icon
As of July 2026, Endo's annual revenue is estimated to be $1B - $10B.

What is Endo's SIC code NAICS code?

Minus sign iconPlus sign icon
Endo's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Endo have currently?

Minus sign iconPlus sign icon
As of July 2026, Endo has approximately 1.5K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Partner: L. C.Senior Vice President Technical Operations: G. M.Director - Analytical Research And Development. Injectable: D. G.. Explore Endo's employee directory with LeadIQ.

What industry does Endo belong to?

Minus sign iconPlus sign icon
Endo operates in the Pharmaceutical Manufacturing industry.

What technology does Endo use?

Minus sign iconPlus sign icon
Endo's tech stack includes Amazon Web ServicesMasterControlCREOSAP ERPModernizrOracle EssbaseNIST Cybersecurity FrameworkAcquia Cloud Site Factory.

What is Endo's email format?

Minus sign iconPlus sign icon
Endo's email format typically follows the pattern of Last.First@endo.com. Find more Endo email formats with LeadIQ.

When was Endo founded?

Minus sign iconPlus sign icon
Endo was founded in 1997.
Endo logo

Endo

Pharmaceutical ManufacturingArkansas, United States1001-5000 Employees

Endo is a pharmaceutical manufacturer based in Malvern, Arkansas, employing a sizeable workforce. In 2025, the company merged with Mallinckrodt Pharmaceuticals to better serve customers and improve outcomes for the patients it supports. As a result, two independent entities were formed: Keenova Therapeutics, focused on branded therapeutics, and Par Health, focused on generics and sterile injectables.

These standalone entities reflect an organizational split within the pharmaceutical manufacturing space, with Keenova handling branded therapies and Par Health handling generics and sterile injectables. Keenova and Par Health maintain a presence on LinkedIn and operate dedicated websites at keenova.com and parhealth.com. In March 2025, Endo announced a new initiative related to spatial computing for injection procedures, marking a notable development in its activities.

Section iconCompany Overview

Phone number
Website
endo.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
ECYT
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
1001-5000

Section iconFunding & Financials

  • $1B - $10B

    Endo's revenue is estimated to be in the range of $1B - $10B

Section iconFunding & Financials

  • $1B - $10B

    Endo's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.